Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

199
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
199
Pneumonia IV: Management01:28

Pneumonia IV: Management

276
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
276
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

191
The pathophysiology of pneumonia involves the following steps:
191
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

131
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
131
Pneumothorax-I01:26

Pneumothorax-I

164
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
164
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

1.7K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overestimation of personal hand hygiene performance and barriers to hand hygiene among healthcare providers.

American journal of infection control·2026
Same author

Leveraging data to advance infection prevention programs.

American journal of infection control·2025
Same author

Global, regional, and national burden of headache disorders, 1990-2021, with forecasts to 2050: A Global Burden of Disease study 2021.

Cell reports. Medicine·2025
Same author

Reactive infectious mucocutaneous eruption.

The American journal of medicine·2025
Same author

Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.

JAMA neurology·2025
Same author

Hand hygiene on gloved hands: is glove integrity compromised by repeated disinfections?

Antimicrobial stewardship & healthcare epidemiology : ASHE·2025
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Related Experiment Video

Updated: May 17, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K

Severe Pneumonia.

Patrick R Ching1, Laura L Pedersen2

  • 1Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, 1000 East Marshall Street, Suite 107, Richmond, VA 23298, USA; Healthcare Infection Prevention Program, Virginia Commonwealth University Health, Richmond, VA, USA.

The Medical Clinics of North America
|April 4, 2025
PubMed
Summary
This summary is machine-generated.

Severe pneumonia, a global health threat, necessitates intensive care due to diverse microbial causes. Early antimicrobial and nonantimicrobial treatments are key to improving patient survival and outcomes.

Keywords:
COVID-19Community-acquired infectionsCritical illnessHospitalizationIntensive care unitPneumoniaSteroidsTherapeutics

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

49.4K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.1K

Related Experiment Videos

Last Updated: May 17, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

49.4K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.1K

Area of Science:

  • Medicine
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Severe pneumonia is a significant global cause of death and illness.
  • It is a complex infectious disease caused by bacteria, viruses, and fungi, often requiring intensive care.
  • Effective management involves prompt antimicrobial therapy and supportive nonantimicrobial interventions.

Purpose of the Study:

  • To provide a comprehensive review of the latest research on severe pneumonia.
  • To cover epidemiology, microbiology, diagnostic approaches, and treatment strategies.
  • To highlight recent advancements in managing this critical condition.

Main Methods:

  • Literature review of recent studies and clinical data.
  • Synthesis of epidemiological trends and etiological factors.
  • Analysis of current diagnostic criteria and therapeutic guidelines.

Main Results:

  • Severe pneumonia remains a major global health challenge with high mortality rates.
  • A diverse range of microorganisms contribute to its pathogenesis.
  • Combined early antimicrobial and nonantimicrobial interventions demonstrate improved patient outcomes.

Conclusions:

  • Prompt diagnosis and multifaceted treatment are crucial for managing severe pneumonia.
  • Continued research into epidemiology, microbiology, and novel therapies is essential.
  • Optimizing patient care through evidence-based strategies can reduce morbidity and mortality.